GRAY BRCA

Men and women with mutations in either the BRCA1 or BRCA2 gene are at an increased risk of developing certain cancers, including breast, ovarian, pancreatic, or prostate. The Gray Foundation aims to transform the prevention, early detection, and treatment of BRCA1/2 mutation-associated cancers by facilitating active collaboration of innovative, multi-institutional research teams aligned with this goal. In addition, these teams are committed to making the resulting data broadly and usefully available to the scientific community via this atlas... ABOUT

Also known as: Gray Foundation